Clinical update on HIV drug resistance to Integrase Inhibitors
Jonathan M. Schapiro MD, is a Clinical Assistant Professor at Stanford University School of Medicine, Stanford, California, and the Director of the AIDS Service, National Hemophilia Center, at Sheba Medical Center,
and completed an internship and residency in the Department of Internal Medicine at Rabin Medical Center, Israel. He completed a postdoctoral fellowship in infectious diseases and geographic medicine at Stanford University School of Medicine.
Dr Schapiro’s work has focused on the study of resistance and cross-resistance between protease inhibitors and the clinical utility of resistance assays. His publications have studied the clinical utility of salvage therapy, the mutational correlates of drug failure and clinical use of genotypic resistance testing. He is also very active in educational initiatives. He codirects the Stanford University HIV Medicine Course and is involved in numerous programs for AIDS-treating physicians.
Dr Schapiro currently shares his time among research, clinical and educational activities in Israel, Europe and the United States.